about
Stathmin destabilizing microtubule dynamics promotes malignant potential in cancer cells by epithelial-mesenchymal transitionMolecular mechanism underlying lymphatic metastasis in pancreatic cancerGenome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populationsNeutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors.Targeted drug delivery in pancreatic cancerClinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in ChinaProfilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis.Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.Overcoming drug resistance in pancreatic cancer.Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancerPreoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinomaMutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.Proteomic analysis of differential proteins in pancreatic carcinomas: Effects of MBD1 knock-down by stable RNA interference.Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden.Application of "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy for normal soft pancreas casesThe Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer.Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?Somatic Genetic Variation in Solid Pseudopapillary Tumor of the Pancreas by Whole Exome Sequencing.Carbon nanotubes in cancer diagnosis and therapy.Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients.Quantum dots in cancer therapy.Role of epidermal growth factor receptor expression on patient survival in pancreatic cancer: a meta-analysis.Stroma and pancreatic ductal adenocarcinoma: an interaction loop.Management of a malignant case of solid pseudopapillary tumor of pancreas: a case report and literature review.Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.Should a standard lymphadenectomy during pancreatoduodenectomy exclude para-aortic lymph nodes for all cases of resectable pancreatic head cancer? A consensus statement by the Chinese Study Group for Pancreatic Cancer (CSPAC).Pancreatic cancer: BRCA mutation and personalized treatment.New insights into perineural invasion of pancreatic cancer: More than pain.A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.Critical role of oncogenic KRAS in pancreatic cancer (Review).Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma.Energy sources identify metabolic phenotypes in pancreatic cancer.Surgical management for non-functional pancreatic neuroendocrine neoplasms with synchronous liver metastasis: A consensus from the Chinese Study Group for Neuroendocrine Tumors (CSNET).Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma.miR-1247 is correlated with prognosis of pancreatic cancer and inhibits cell proliferation by targeting neuropilins.
P50
Q26852630-20832D84-178B-4AF7-AEDD-D940BB91043DQ26999345-4F769B49-FCCF-4A67-A684-A4951B326E13Q28943254-703783DB-1EE9-451F-9D34-9FDE4EDFDB69Q33598412-B601CD57-D904-4AA4-8F96-515E0D66FBCEQ33598860-B8228DFD-1118-4101-90C5-E50F81E15602Q33625651-E25F824C-2C00-4B50-B6A9-4CCF4D3C6E91Q33684746-8FE442A6-548F-4B39-82E9-0E6C7C5BD2E3Q34598059-E365A9F8-0463-473D-B015-F524B6A61853Q34937019-3686D374-0BEB-4EE8-9E72-D6DF1A7E52F0Q35036615-CD846147-1571-4F03-B01A-3F590E7E7DD1Q35142413-2C9795B7-78DA-45C9-9895-B1EFB07DCBCDQ35578938-6A239DBA-DE94-4FC9-9D6C-221FE4B576C5Q36151583-370DE028-2570-4D86-ADC8-65DDE3548D6AQ36453968-EDAFB189-5609-4431-A19C-5A480EB91CBDQ36661553-F2DBE28A-6B11-4548-A4A2-72C38B08B93FQ36747316-DA8CAF97-7078-4D08-87C0-686BA8B4873CQ36905807-7C525487-6DFC-42C5-A67B-1D77189BD1CBQ36952327-03D133FF-8AEC-4890-BCEB-98687E4163A4Q37134542-674F74EB-974C-4817-9743-C4959D1A2F08Q37301771-FD6E8B1F-6AD7-46DF-A2D4-783464B3DCFAQ37631505-DC0B4592-D7FF-416D-9E01-4B423BC17038Q37700981-ACAF62D7-D695-4596-BDE9-203CB4A75233Q37701172-EB899932-0116-40D7-85C7-CC3D2EC74872Q37968640-0F8A290E-BCB8-46FE-ACC4-EF92B8A2A369Q37977292-CFAAA074-929A-4071-B422-53D665E7C8C2Q38004291-2FD33AB0-48DD-4C92-927C-6DA33E9E412BQ38018802-C76753F5-AE60-430E-ACE8-578C51745991Q38272327-AE5DA28C-296F-4C64-B0BB-E3EB32411D11Q38330886-1794820B-B3B6-465B-ABD4-D864D09F4C73Q38575271-A79FA72C-BEE6-4992-AC55-8277FE98CCB9Q38592167-9F17DFBE-9269-44C9-9B53-715CD58ED971Q38705686-14503EB4-137D-4469-967D-75D535B8490EQ38710064-6A557C8A-9B88-41B3-ABAB-9C4FBF3770EBQ38795704-9EC97004-589E-4767-AF44-FA117572EEE6Q38819216-143EF712-5924-4B59-B3F8-056874F902EEQ38947830-AA100F85-0474-462F-AA62-FF070520F39DQ38959840-A3E52C79-0A87-42DD-829F-42C692AB95A3Q39003409-0C5F5214-F490-4C9D-BF3B-503A21991354Q39008827-76C8F229-59B5-4F5C-8585-D66CE74B4DC8Q39019140-8E4AE560-1C96-469C-90B5-CED0A63E51EF
P50
description
researcher ORCID ID = 0000-0002-6697-7143
@en
wetenschapper
@nl
name
Xianjun Yu
@ast
Xianjun Yu
@en
Xianjun Yu
@es
Xianjun Yu
@nl
type
label
Xianjun Yu
@ast
Xianjun Yu
@en
Xianjun Yu
@es
Xianjun Yu
@nl
prefLabel
Xianjun Yu
@ast
Xianjun Yu
@en
Xianjun Yu
@es
Xianjun Yu
@nl
P1153
7404114593
P31
P496
0000-0002-6697-7143